The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase
Abstract
In this study, we provide a molecular signature of highly enriched CD34+ cells from bone marrow of untreated patients with chronic myelogenous leukemia (CML) in chronic phase in comparison with normal CD34+ cells using microarrays covering 8746 genes. Expression data reflected several BCR-ABL-induced effects in primary CML progenitors, such as transcriptional activation of the classical mitogen-activated protein kinase pathway and the phosphoinositide-3 kinase/AKT pathway as well as downregulation of the proapoptotic gene IRF8. Moreover, novel transcriptional changes in comparison with normal CD34+ cells were identified. These include upregulation of genes involved in the transforming growth factorbeta pathway, fetal hemoglobin genes, leptin receptor, sorcin, tissue inhibitor of metalloproteinase 1, the neuroepithelial cell transforming gene 1 and downregulation of selenoprotein P. Additionally, genes associated with early hematopoietic stem cells (HSC) and leukemogenesis such as HoxA9 and MEIS1 were transcriptionally activated. Differential expression of differentiation-associated genes suggested an altered composition of the CD34+ cell population in CML. This was confirmed by subset analyses of chronic phase CML CD34+ cells showing an increase of the proportion of megakaryocyte-erythroid progenitors, whereas the proportion of HSC and granulocyte-macrophage progenitors was decreased in CML. In conclusion, our results give novel insights into the biology of CML and could provide the basis for identification of new therapeutic targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Gene set enrichment analysis showed that genes on AML-specific loops were enriched in hematopoiesis and myeloid transformation pathways28,29 (Extended Data Fig. 4c).”
From Subtype-specific 3D genome alteration in acute myeloid leukaemia (2022) · cites this paper as [29]
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data
Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J., Ansorge, W., Ball, C. A., Causton, H. C., et al. (2001) · Nature Genetics · doi:10.1038/ng1201-365 · Cited by 4,109
Huber, W., von Heydebreck, A., Sültmann, H., Poustka, A., & Vingron, M. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.suppl_1.s96 · Cited by 2,440
Daley, G. Q., Etten, R. A. V., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 2,141
The molecular biology of chronic myeloid leukemia
Deininger, M. W., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,654
The Biology of Chronic Myeloid Leukemia
Faderl, S. H., Talpaz, M., Estrov, Z. E., O'Brien, S. M., Kurzrock, R., & Kantarjian, H. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410306 · Cited by 1,322
Intracellular signalling pathways activated by leptin
Frühbeck, G. (2005) · Biochemical Journal · doi:10.1042/bj20051578 · Cited by 851
Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton
Tapon, N. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80156-1 · Cited by 819
Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells
Gainsford, T., Willson, T. A., Metcalf, D., Handman, E., McFarlane, C., Ng, A. P., Nicola, N. A., Alexander, W. S., & Hilton, D. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14564 · Cited by 758
Intracellular signalling pathways activated by leptin
Frühbeck, G. (. (2006) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · Cited by 745
Donato, N. J., Wu, J. Y., Stapley, J., Gallick, G. E., Lin, H., Arlinghaus, R. B., & Talpaz, M. (2002) · Blood · doi:10.1182/blood.v101.2.690 · Cited by 677
Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644
Gene expression changes associated with progression and response in chronic myeloid leukemia
Radich, J. P., Dai, H., Mao, M., Oehler, V., Schelter, J., Druker, B., Sawyers, C., Shah, N., Stock, W., Willman, C. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510423103 · Cited by 583
Skorski, T., Bellacosa, A., Nieborowska‐Skorska, M., Majewski, M., Martinez, R., Choi, J. K., Trotta, R., Wlodarski, P., Perrotti, D., Chan, T. O., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6151 · Cited by 567
Storms, R. W., Sindram-Trujillo, A. P., Springer, J. B., Shah, L., Colvin, O. M., Ludeman, S. M., & Smith, C. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9118 · Cited by 552
Bhatia, R., Holtz, M. S., Niu, N., Gray, R., Snyder, D., Sawyers, C. L., Arber, D. A., Slovak, M. L., & Forman, S. J. (2003) · Blood · doi:10.1182/blood-2002-09-2780 · Cited by 552
Prospective isolation of human clonogenic common myeloid progenitors
Manz, M. G., Miyamoto, T., Akashi, K., & Weissman, I. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172384399 · Cited by 529
The hematopoietic stem cell in its place
Adams, G. B., & Scadden, D. T. (2006) · Nature Immunology · doi:10.1038/ni1331 · Cited by 450
Gordon, M. Y., Dowding, C., Riley, G. P., Goldman, J. M., & Greaves, M. F. (1987) · Nature · doi:10.1038/328342a0 · Cited by 436
McWhirter, J. R., Galasso, D. L., & Wang, J. Y. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7587 · Cited by 422
Skórski, T., Kanakaraj, P., Nieborowska-Skorska, M., Ratajczak, M. Z., Wen, S. C., Zon, G., Gewirtz, A., PERUSSIA, B., & Calabretta, B. (1995) · Blood · doi:10.1182/blood.v86.2.726.bloodjournal862726 · Cited by 405
Dominant negative MYC blocks transformation by ABL oncogenes
Sawyers, C. L., Callahan, W., & Witte, O. N. (1992) · Cell · doi:10.1016/0092-8674(92)90241-4 · Cited by 395
The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.
Raitano, A., Halpern, J., Hambuch, T. M., & Sawyers, C. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11746 · Cited by 394
Horita, M., Andreu, E. J., Benito, A., Arbona, C., Sanz, C., Benet, I., Prósper, F., & Fernández-Luna, J. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.977 · Cited by 366
Hematopoietic cytokines, transcription factors and lineage commitment
Zhu, J., & Emerson, S. G. (2002) · Oncogene · doi:10.1038/sj.onc.1205318 · Cited by 349
Pineault, N., Helgason, C. D., Lawrence, H. J., & Humphries, R. K. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00757-3 · Cited by 278
Pizer, E. S., Chrest, F. J., DiGiuseppe, J. A., & Han, W. F. (1998) · PubMed · Cited by 250
STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells
Sillaber, C., Gesbert, F., Frank, D. A., Sattler, M., & Griffin, J. D. (2000) · Blood · doi:10.1182/blood.v95.6.2118 · Cited by 222
Cortez, D., Reuther, G. W., & Pendergast, A. M. (1997) · Oncogene · doi:10.1038/sj.onc.1201400 · Cited by 221
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation
Notari, M., Neviani, P., Santhanam, R., Blaser, B. W., Chang, J.-S., Galietta, A., Willis, A. E., Roy, D., Caligiuri, M. A., Marcucci, G., et al. (2005) · Blood · doi:10.1182/blood-2005-09-3732 · Cited by 202
Konopleva, M. Y., Mikhail, A. A., Estrov, Z. E., Zhao, S., Harris, D., Sanchez‐Williams, G., Kornblau, S. M., Dong, J., Kliche, K. O., Jiang, S., et al. (1999) · Blood · doi:10.1182/blood.v93.5.1668 · Cited by 188
Zermati, Y., Fichelson, S., Valensi, F., Freyssinier, J. M., Rouyer‐Fessard, P., Cramer, E. M., Guichard, J., Varet, B. R., & Hermine, O. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00488-4 · Cited by 179
Steidl, U. U., Kronenwett, R., Rohr, U., Fenk, R. R., Kliszewski, S., Maercker, C., Neubert, P., Aivado, M. A., Koch, J., Modlich, O., et al. (2002) · Blood · doi:10.1182/blood.v99.6.2037 · Cited by 148
Self-citationHao, S. X., & Ren, R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1149-1161.2000 · Cited by 143
Andreu, E. J., Lledó, E., Poch, E., Ivorra, C., Albero, M. P., Martinez-Climent, J. A., Montiel‐Duarte, C., Rifón, J., Pérez‐Calvo, J., Arbona, C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1357 · Cited by 142
Yong, A. S. M., Szydlo, R., Goldman, J. M., Apperley, J. F., & Melo, J. V. (2005) · Blood · doi:10.1182/blood-2005-05-2155 · Cited by 139
Expression of Dominant-Negative Mutant DP-1 Blocks Cell Cycle Progression in G 1
Wu, C., Classon, M., Dyson, N. J., & Harlow, E. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3698 · Cited by 139
Bcr/Abl expression stimulates integrin function in hematopoietic cell lines.
Bazzoni, G., Carlesso, N., Griffin, J. D., & Hemler, M. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118820 · Cited by 126
Zheng, C., Li, L., Haak, M., Brors, B., Frank, O., Giehl, M., Fabarius, A. C., Schatz, M. C., Weisser, A., Lorentz, C., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404227 · Cited by 117
Self-citationDurkin, M. E., Avner, M. R., Huh, C.-G., Yuan, B., Thorgeirsson, S. S., & Popescu, N. C. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.12.090 · Cited by 116
Shen, X., Li, J., Hu, P. P.-C., Waddell, D. S., Zhang, J., & Wang, X. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009534200 · Cited by 116
Chronic myelogenous leukemia molecular signature
Nowicki, M. O., Pawlowski, P., Fischer, T. H., Heß, G., Pawlowski, T., & Skórski, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206620 · Cited by 114
Activation of RhoA and SAPK/JNK signalling pathways by the RhoA‐specific exchange factor mNET1
Alberts, A. S., & Treisman, R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.14.4075 · Cited by 114
Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach
Villuendas, R., Steegmann, J. L., Pollán, M., Tracey, L., Granda, A., Fernández‐Ruiz, E., Casado, L., Martínez‐López, J., Martinez, P. B., Lombardía, L., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404197 · Cited by 111
Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients
Frank, O., Brors, B., Fabarius, A. C., Li, L., Haak, M., Merk, S., Schwindel, U., Zheng, C., Müller, M. C., Gretz, N., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404270 · Cited by 110
Self-citationThe Adapter Protein Crkl Links Cbl to C3G after Integrin Ligation and Enhances Cell Migration
Uemura, N., & Griffin, J. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37525 · Cited by 110
Dai, Z., Quackenbush, R. C., Courtney, K. D., Grove, M., Cortez, D., Reuther, G. W., & Pendergast, A. M. (1998) · Genes & Development · doi:10.1101/gad.12.10.1415 · Cited by 109
Janowska‐Wieczorek, A., Marquez‐Curtis, L. A., Matsuzaki, A., Hashmi, H., Larratt, L. M., Boshkov, L., Turner, A. R., Zhang, M., Edwards, D. R., & Kossakowska, A. E. (1999) · British Journal of Haematology · doi:10.1111/j.1365-2141.1999.01352.x · Cited by 107
Burchert, A. (2003) · Blood · doi:10.1182/blood-2003-08-2970 · Cited by 102
Wang, G. G., Pasillas, M. P., & Kamps, M. P. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.10.3902-3916.2006 · Cited by 97
Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival
Lambert, E., Boudot, C., Kadri, Z., Soula-Rothhut, M., Sowa, M.-L., Mayeux, P., Hornebeck, W., Haye, B., & Petitfrere, E. (2003) · Biochemical Journal · doi:10.1042/bj20030187 · Cited by 94
Ng, Y. Y., van Kessel, B., Lokhorst, H. M., Baert, M. R. M., van den Burg, C. M. M., Bloem, A. C., & Staal, F. J. T. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603287 · Cited by 90
Ohmine, K., Ota, J., Ueda, M., Ueno, S., Yoshida, K., Yamashita, Y., Kirito, K., Imagawa, S., Nakamura, Y., Saito, K., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1205029 · Cited by 79
McLean, L. A., Gathmann, I., Capdeville, R., Polymeropoulos, M. H., & Dressman, M. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0784-3 · Cited by 79
Konopleva, M. Y., Mikhail, A. A., Estrov, Z. E., et al. (1999) · Blood · doi:10.1182/blood.v93.5.1668.405a15_1668_1676 · Cited by 78
Peled, A., Hardan, I., Trakhtenbrot, L., Gur, E., Magid, M., Darash‐Yahana, M., Cohen, N., Grabovsky, V., Franitza, S., Kollet, Ó., et al. (2002) · Stem Cells · doi:10.1634/stemcells.20-3-259 · Cited by 77
Eaves, A., & Eaves, C. (1979) · PubMed · Cited by 65
Park, B.-K. (2001) · Immune Network · doi:10.4110/in.2001.1.2.109 · Cited by 60
Chronic myeloid leukaemia: stem cell derived but progenitor cell driven
Marley, S. B., & Gordon, M. Y. (2005) · Clinical Science · doi:10.1042/cs20040336 · Cited by 59
Kronenwett, R., Butterweck, U., Steidl, U. U., Kliszewski, S., Neumann, F., Bork, S., Blanco, E. D., Roes, N., Graef, T. T., Brors, B., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208596 · Cited by 59
Self-citationSalesse, S., & Verfaillie, C. M. (2002) · Oncogene · doi:10.1038/sj.onc.1206088 · Cited by 54
Qin, H., Carr, H. S., Wu, X., Muallem, D. R., Tran, N. H., & Frost, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412141200 · Cited by 53
Staal, F. J. T., Cario, G., Cazzaniga, G., Haferlach, T., Heuser, M., Hofmann, W. ‐., Mills, K., Schrappe, M., Stanulla, M., Wingen, L. U., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404274 · Cited by 53
Expression of the leptin receptor in human leukaemic blast cells
Nakao, T., Hino, M., Yamane, T., Nishizawà, Y., Morii, H., & Tatsumi, N. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00843.x · Cited by 52
Localization of BCR-ABL to F-actin regulates cell adhesion but does not attenuate CML development
Wertheim, J. A., Perera, S. A., Hammer, D. A., Ren, R., Boettiger, D. C., & Pear, W. S. (2003) · Blood · doi:10.1182/blood-2003-01-0062 · Cited by 48
Nakata, Y., Tomkowicz, B. E., Gewirtz, A. M., & Ptasznik, A. (2006) · Blood · doi:10.1182/blood-2005-08-3343 · Cited by 47
Williams, C. D., Linch, D. C., Watts, M., & Thomas, N. S. B. (1997) · Blood · doi:10.1182/blood.v90.1.194 · Cited by 47
Malhotra, K., Malhotra, K., Lubin, B. H., & Kuypers, F. A. (1999) · Biochemical Journal · doi:10.1042/bj3440135 · Cited by 45
Bhanu, N. V., Trice, T. A., Lee, Y. T., Gantt, N. M., Oneal, P. A., Schwartz, J. D., Noël, P., & Miller, J. L. (2004) · Blood · doi:10.1182/blood-2004-04-1599 · Cited by 39
Biological effects of stroma-derived factor-1α on normal and CML CD34+ haemopoietic cells
Dürig, J., Rosenthal, C., Elmaagacli, A. H., Heyworth, C. M., Halfmeyer, K., Kasper, C., Novotný, J., & Dührsen, U. (2000) · Leukemia · doi:10.1038/sj.leu.2401875 · Cited by 39
Differences between normal and cml stem cells: Potential targets for clinical exploitation
Eaves, A. C., Barnett, M. J., Ponchio, L., Cashman, J., Petzer, A. L., & Eaves, C. J. (2009) · Stem Cells · doi:10.1002/stem.5530160809 · Cited by 36
GCKR Links the Bcr-Abl Oncogene and Ras to the Stress-Activated Protein Kinase Pathway
Shi, C.-S., Tuscano, J. M., Witte, O. N., & Kehrl, J. H. (1999) · Blood · doi:10.1182/blood.v93.4.1338 · Cited by 34
Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
MUROHASHI, I., Endho, K., Nishida, S., Yoshida, S., Jinnai, I., Bessho, M., & HIRASHIMA, K. (1995) · PubMed · Cited by 32
Böhmer, R. M., Campbell, T. A., & Bianchi, D. W. (2000) · Blood · doi:10.1182/blood.v95.9.2967.009k21_2967_2974 · Cited by 31
Leptin: A Promising Therapeutic Target with Pleiotropic Action Besides Body Weight Regulation
Paraskevas, K. I., Liapis, C. D., & Mikhailidis, D. P. (2006) · Current Drug Targets · doi:10.2174/138945006777435371 · Cited by 27
Primo, D., Flores-Montero, J. A., Quijano, S., Sánchez, M. L., Sarasquete, M. E., del Pino‐Montes, J., Gaarder, P. I., González, M., & Órfão, A. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06265.x · Cited by 27
Inhibition of angiogenesis in vitro by αv integrin–directed antisense oligonucleotides
Kronenwett, R., Graef, T. T., Nedbal, W., Weber, M., Steidl, U. U., Rohr, U., Möhler, T., & Haas, R. R. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700474 · Cited by 22
Self-citationNeumann, F., Teutsch, N., Kliszewski, S., Bork, S., Steidl, U. U., Brors, B., Schimkus, N., Roes, N., Germing, U., Hildebrandt, B., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403615 · Cited by 20
Self-citation
Cited by
Sorted by citations
Baccarani, M., Cortes, J. E., Pane, F., Niederwieser, D. W., Saglio, G. N., Apperley, J. F., Cervantes, F., Deininger, M. W., Gratwohl, A. A., Guilhot, F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0779 · Cited by 1,276
The IRF Family Transcription Factors in Immunity and Oncogenesis
Tamura, T., Yanai, H., Savitsky, D., & Taniguchi, T. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090400 · Cited by 1,259
Regulation of immunity and oncogenesis by the IRF transcription factor family
Savitsky, D., Tamura, T., Yanai, H., & Taniguchi, T. (2010) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-009-0804-6 · Cited by 298
Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow
Lee, J., Breton, G., Oliveira, T. Y., Zhou, Y. J., Aljoufi, A., Puhr, S., Cameron, M. J., Sékaly, R., Nussenzweig, M. C., & Liu, K. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20141442 · Cited by 258
Myc Roles in Hematopoiesis and Leukemia
Delgado, M. D., & León, J. (2010) · Genes & Cancer · doi:10.1177/1947601910377495 · Cited by 253
Metadata
- Authors
- Diaz-Blanco, E., Bruns, I., Neumann, F., Fischer, J. C., Graef, T., Rosskopf, M., Brors, B., Pechtel, S., Bork, S., Koch, A., Baer, A., Rohr, U.-P., Kobbe, G., Haeseler, A. V., Gattermann, N., Haas, R., & Kronenwett, R.
- Affiliations
- Heinrich Heine University Düsseldorf (DE)
- German Cancer Research Center (DE)
- University of Vienna (AT)
- Corresponding author
- Kronenwett, R
- ORCID
- Venue
- Leukemia
- Published
- 2007-01-25
- Volume
- 21
- Issue
- 3
- Pages
- 494-504
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2564723484
- Cited by
- 148
- References
- 78
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 4 · 2021: 10 · 2020: 6 · 2019: 6 · 2018: 2 · 2017: 8 · 2016: 4 · 2015: 10 · 2014: 5 · 2013: 12 · 2012: 7
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Leukemia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- chronic myeloid leukemia, chronic phase, CD34+ hematopoietic stem and progenitor cells, BCR-ABL, gene expression signatures, MAPK signaling, phosphoinositide 3-kinase/Akt pathway, IRF8, HOXA9, MEIS1, megakaryocyte-erythroid progenitors, CFU-GM, fetal hemoglobin, selenoprotein P, leukemogenesis, therapeutic target
- MeSH terms
- Cell Adhesion, Cell Differentiation, Cell Division, DNA, Neoplasm, Hematopoietic Stem Cells, Humans, Neoplasm Proteins, Receptors, Cell Surface, RNA, Messenger, RNA, Neoplasm, Neoplastic Stem Cells, Signal Transduction, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Up-Regulation, Gene Expression Regulation, Leukemic, Fusion Proteins, bcr-abl, Apoptosis, Receptors, Growth Factor, DNA, Complementary, Antigens, CD34, Gene Expression Profiling, Intercellular Signaling Peptides and Proteins, Receptors, Leptin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review